The Council of the European Union is one of the most important institutions involved in the EU’s decision-making process. But despite a ruling by the highest EU court and increased demands from civil society, they refuse to sign up to the transparency register, writes Andreas Pavlou.
There is a stubbornly held opinion that the European Union is non-transparent and vulnerable to the interests of lobbyist. But a hidden agenda of interests in Brussels and Strasbourg is hardly possible and in terms of transparency, the European Union is even way ahead of its own member states, argues Jo Leinen.
Two years after Dieselgate put the issue of corporate capture into the limelight, EU institutions have the perfect opportunity to get tough on lobbying, through a comprehensive reform of the EU lobby transparency, writes Myriam Douo.
The European Union should require companies operating in Africa to disclose the taxes they pay there more transparently, to ensure they contribute fairly to government revenues, French economist Thomas Piketty said on Thursday (10 September).
The European Parliament has given its final approval for tough new disclosure rules for energy and mining firms, just as Canadian premier Stephen Harper announces similar rules in London in a bid analysts say is designed to smooth over bad headlines on tar sands.
SPECIAL REPORT / Public health should become part of the common EU policies and legislation “in a very structured way”, argues Bulgarian MEP Antonyia Parvanova, rapporteur on the Transparency Directive aimed at speeding up the entry into the market of new medicines.
The European Parliament will oppose cuts to the EU health budget for 2014-2020, MEP Antonyia Parvanova (ALDE, Bulgaria) told EURACTIV in an interview. She also says the proposed budget of €50 million per year for 28 member states is too modest.
A European Parliament panel voted yesterday (18 September) to strengthen financial disclosure rules designed to deter corruption in foreign mining, petroleum and forestry investments, putting the draft EU rules in line with a stringent law adopted this summer in the United States.
Several European Commission 2012 initiatives will impact healthcare innovation. The Horizon 2020 research programme will seek to link the health industry, public sector and academia in new research clusters. A revision to the Directive on Clinical Trials will seek to promote health research and innovation. Meanwhile, the Transparency Directive will ensure that research efforts translate into faster access to much- needed medicines.